Bellevue Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
CIP
FLAM
DSCM
Bellevue Group's ATRC Position: Q3 2024 in Review
Bellevue Group sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 212,559 shares — an estimated $4.84M sold.
Bellevue Group first reported a position in ATRC in Q4 2020 and held it in 15 quarters. The position peaked at $39.3M in Q1 2022. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.
- Bellevue Group reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
- Bellevue Group sold 212,559 AtriCure shares in Q3 2024, an estimated $4.84M.
- Bellevue Group first reported a position in AtriCure in Q4 2020 and held it in 15 quarters.
- Bellevue Group's AtriCure position peaked at $39.3M in Q1 2022.
- 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.
Based on Bellevue Group's 13F filing for Q3 2024, filed 14 Nov 2024.